Correction  by unknown
CORRECTION
In the March 2012 issue of the Journal of Vascular Surgery, the article by Dr Donas et al (Donas KP, Pecoraro F,
Torsello G, Lachat M, AustermannM,Mayer D, et al. Use of covered chimney stents for pararenal aortic pathologies
is safe and feasible with excellent patency and low incidence of endoleaks. J Vasc Surg 2012;55:659-65) listed an error
in Table I. The endoleak type I row should have listed the total number of patients in the self-expanding covered stent
group as 35. The corrected table is as follows:
CORRECTION
In the March 2012 issue of the Journal of Vascular Surgery, the article by Dr Comerota et al (Comerota AJ, Grewal
N, Martinez JT, Chen JT, DiSalle R, Andrews L, et al. Postthrombotic morbidity correlates with residual thrombus
following catheter-directed thrombolysis for iliofemoral deep vein thrombosis. J Vasc Surg 2012;55:768-73) listed
an error in Table I. The Villalta scores for group 1 and group 2 were reversed. The corrected table is as follows:
Table I. Patients demographics and characteristics
Balloon-covered expandable
stent group
Self-expanding covered
stent group P
Age, years 74.5  7.3 72.4  8.3 .07
Men 34/37 30/35 .32
Size of the aneurysm, cm 6.2 6.6 .11
Infrarenal with short neck (9 mm)/pararenal aneurysm 36/37 25/35 .002
Pseudoaneurysm 0/37 6/35 .01
Endoleak type I 1/37 4/35 .15
Creatinine (mg/dL, mean  SD) 1.2  0.5 1.2  0.9 .34
Estimated glomular filtration rate (mL/min/1.73m2, mean  SD) 63  28 54.1  9 .40
Comorbidities
Cardiac 27 29 .24
Renal (creatinine 100 mg/mL) 8 13 .12
Respiratory 11 19 .03
Previous aortic intervention 11 15 .18
Previous aortocoronary bypass or intervention 11 9 .45
Previous myocardial infarction 9 8 .55
Informed consent was obtained from all patients.
Table I. CEAP and Villalta scores of patients per group
CEAP
(median)
Villalta
(mean)
Group 1 (50% residual thrombus) 1 2.21
Group 2 (50% residual thrombus) 4 7.13
P value .025 .0111547
